We are celebrating 22 years in Business - Thank You For Making Us The #1 Go To Site for Your Health Care

hematology, medical oncology, oncology review course, board review, recalled oncology questions, breast cancer, radiation, bone, cervix, breast, lymphoma, oncology, pediatrics, breast surgery, colon, hydrotherapy, prostate, prostate cancer, oncology board review questions, bladder, bone tumors, bladder, wilms tumor, hematology, colon, testicular, radiation therapy, radiation treatment, colon cancer, skin, carcinoma, endometrium, bone marrow, bone cancer, tumors, radiation, bone tissue, breast cancer, skin diseases, gynecology, rhabdo, myosarcoma, whole body radiation, hyperfractionation, head neck, thymomas, mediastinal masses, cns tumors, esophagus, renal carcinoma, desmoid tumor of the abdominal wall, neuro, radiation oncology, google, comprehensive board review, devita, hellman, rosenbergs cancer, e-book, e-books, Amazon Kindle, Palm, mobipocket, pda books, PDF, Iliad, DRM-free, Palm DOC, RTF, EPUB

Medical-technology-news

The latest cancer news for cancer research. Inform yourselves about the newest technologies, best practices and studies in the field of cancer diseases and tumors.

  • RNA molecules that regulate action of male hormone in prostate cancer identified July 18, 2018
    A study detected in tumoral tissue hundreds of RNAs that do not encode proteins but appear to regulate effects of androgens and androgen receptors on gene expression in tumors. By investigating the connection between the presence of these molecules and tumor aggressiveness, the research paves the way for new scientific approaches focusing on the transcriptio […]
  • Melanoma biomarkers predicting checkpoint blocker response July 18, 2018
    Scientists have identified biomarkers in melanoma that could help tailor immunotherapy treatments to maximize the benefits for patients while reducing the likelihood of severe side effects.
  • Scientists uncover DNA 'shield' w/crucial roles in normal cell division July 18, 2018
    New fundamental complex in cells drives 'messy' form of DNA repair. In immune cells, this is crucial to make antibodies. In cancer, mutations in complex could lead to resistance to BRCA-targeting PARP inhibitor drugs or platinum chemotherapies.
  • Scientists discover a mechanism of drug resistance in breast and ovarian cancer July 18, 2018
    A new study helps explain why certain cancers don't respond to treatment, and offers hope for overcoming this deadly resistance.
  • Researchers solve mystery of how ALL enters the central nervous system July 18, 2018
    A deadly feature of acute lymphoblastic leukemia (ALL) is its invasion of the central nervous system. ALL in the central nervous system is very difficult to treat, because most drugs are blocked from the organ system due to a "blood-brain barrier" designed to protect the brain. How cancer cells enter the central nervous system has been an unanswere […]
  • New breast cancer therapeutic target July 18, 2018
    Research has shown for the first time that a tiny piece of RNA deregulates energy metabolism, an emerging hallmark of cancer. The finding identifies a new target for therapeutic intervention in breast cancer.
  • Link found between bitter-taste sensitivity and cancer risk July 18, 2018
    High bitter-taste sensitivity is associated with a significantly increased risk of cancer in older British women, according to researchers who conducted a unique study of 5,500 women whose diet, lifestyle and health has been tracked for about 20 years.

CancerGroup.com